1. Home
  2. BGIN vs STTK Comparison

BGIN vs STTK Comparison

Compare BGIN & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGIN

Bgin Blockchain Limited Class A Ordinary Shares

N/A

Current Price

$2.55

Market Cap

332.6M

Sector

N/A

ML Signal

N/A

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

N/A

Current Price

$6.00

Market Cap

275.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGIN
STTK
Founded
2019
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.6M
275.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BGIN
STTK
Price
$2.55
$6.00
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$7.00
AVG Volume (30 Days)
4.2K
569.6K
Earning Date
01-01-0001
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.02
EPS
N/A
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.38
$0.69
52 Week High
$5.19
$6.00

Technical Indicators

Market Signals
Indicator
BGIN
STTK
Relative Strength Index (RSI) 39.42 81.39
Support Level $2.43 $3.67
Resistance Level $2.99 N/A
Average True Range (ATR) 0.13 0.36
MACD -0.01 0.21
Stochastic Oscillator 15.15 95.87

Price Performance

Historical Comparison
BGIN
STTK

About BGIN Bgin Blockchain Limited Class A Ordinary Shares

BGIN Blockchain Ltd is operating through its subsidiaries and is engaged in digital asset technology company based in Singapore, Hong Kong and the U.S. with proprietary cryptocurrency-mining technologies and a strategic focus on alternative cryptocurrencies. It design and sell mining machines equipped with proprietary 8nm or 12nm ASIC chips under different series dedicated to the mining of KAS coins, ALPH coins, and RXD coins. The Company operated in two reportable segments, which were the cryptocurrency mining and the sale of mining machines Key revenue is generated from Sale of mining machines. Geographically, It derives key revenue from Hong Kong, China and Vietnam, United States, Singapore, etc.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: